Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-02-20

Clinical Trial Update: Korean Study on Safety and Effectiveness of OAD Triple Therapy in Type 2 Diabetes

View source ↗

Summary

A Korean study is evaluating the safety and effectiveness of a triple oral antidiabetic drug therapy for Type 2 diabetes. The sponsor is Chong Kun Dang Pharmace…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Chong Kun Dang Pharmaceutical | Conditions: Diabetes Mellitus, Type 2 | Status: RECRUITING